Uno Medical Trials Kft.

At Uno Medical Trials Kft. in Budapest, cardiovascular research focuses on atrial fibrillation and heart failure. These studies are designed to assess whether new treatment approaches can better prevent serious complications and improve outcomes for people living with common heart-related conditions.

• Preventing stroke and other embolic events in atrial fibrillation
• Improving treatment options for heart failure
• Evaluating the safety and effectiveness of new cardiovascular therapies

This area reflects a strong interest in testing therapies that may reduce risk and support longer-term heart health.

The site is active in immune system disease research, especially for psoriatic arthritis. These trials aim to relieve inflammation, reduce joint symptoms, and compare how well emerging treatments work for people who have not responded well to earlier therapies.

• Treating active psoriatic arthritis
• Comparing new options for patients with prior treatment limitations
• Assessing symptom control and overall treatment benefit

This work helps expand choices for immune-mediated conditions where long-term control can be challenging.

Research in nervous system diseases includes multiple sclerosis, migraine, and chronic pain due to diabetic peripheral neuropathy. The studies are focused on easing symptoms, slowing disease-related worsening, and understanding whether new therapies can offer more durable relief.

• Supporting people with relapsing multiple sclerosis and primary progressive multiple sclerosis
• Testing treatments for acute migraine relief
• Evaluating approaches for diabetic peripheral neuropathy pain

The research portfolio at Uno Medical Trials Kft. shows a broad effort to improve both symptom management and long-term neurological outcomes.

In nutritional and metabolic diseases, the trials center on hypertriglyceridemia and severe hypertriglyceridemia. These studies are intended to determine whether new therapies can lower triglyceride levels and support better metabolic and cardiovascular risk management.

• Reducing elevated triglyceride levels
• Addressing hypertriglyceridemia and more severe forms of the condition
• Assessing long-term safety of lipid-lowering treatments

This area highlights research aimed at improving treatment options for patients with persistent metabolic risk.

The site also conducts substantial work in skin and connective tissue diseases, particularly plaque psoriasis. These trials are examining whether newer therapies can improve skin clearance, reduce disease activity, and provide lasting control for moderate to severe disease.

• Studying moderate to severe plaque psoriasis
• Evaluating treatments for psoriatic arthritis with skin and joint involvement
• Comparing new therapies with established options to improve effectiveness

The research reflects ongoing efforts to advance care for chronic inflammatory skin conditions and related joint disease.